India's Tamil Nadu State Puts 24 Drugs, Devices On Substandard List
This article was originally published in PharmAsia News
India's southernmost state of Tamil Nadu has placed 24 drugs and medical devices on its blacklist of substandard drugs so far this year, including products ranging from over-the-counter drugs to needles and syringes.
You may also be interested in...
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.
The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.
The US FDA commissioner published a blog post commending and highlighting the work device center staff have done during the pandemic to speed tests and devices to market to save lives.